Pfizer asks Japan to approve COVID jab for kids
Health
- 10 November, 2021
- 06:24
Pfizer has asked Japan’s health ministry for approval to use its vaccine on children aged 5 to 11, the company said in a statement, Report informs referring to Nikkei Asia.
Pfizer’s vaccine - developed with BioNTech - was the first jab approved for the general public in February.
The vaccine is currently for persons aged 12 and above. If approved, Pfizer’s jab will be the first one in Japan available for children under 11.
To date, 77.8% of the population has received at least one dose in Japan, where Pfizer/BioNTech, Moderna or AstraZeneca coronavirus vaccines are allowed. 73.1% of the Japanese population are fully vaccinated.
Latest News
21:32
President Ilham Aliyev made Novruz holiday post on social media accounts
Domestic policy21:00
Volodymyr Zelenskyy: US, Ukraine, Russia agree on principles for monitoring ceasefire
Other countries20:55
Supreme Leader Khamenei says Iran hasn't targeted Turkiye or Oman
Region20:50
Damage reported in Jerusalem's Old City after Iranian missile barrage
Other countries20:45
Chuck Norris dies aged 86
Show business20:38
Araghchi reiterates Iran will show ‘zero restraint' if infrastructure hit again
Region20:29
Pashinyan: Rejection of peace with Azerbaijan - fatal threat to Armenia's security
Region20:25
NATO says it is 'adjusting' mission in Iraq
Other countries20:15